Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

Inspire Medical Systems (INSP) Competitors

Inspire Medical Systems logo
$71.09 -1.57 (-2.16%)
Closing price 10/23/2026 03:59 PM Eastern
Extended Trading
$71.20 +0.11 (+0.16%)
As of 10/23/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

INSP vs. TFX, HAE, MMED, ITGR, and LIVN

Should you buy Inspire Medical Systems stock or one of its competitors? Inspire Medical Systems's main competitors and comparable companies include Teleflex (TFX), Haemonetics (HAE), MiniMed Group (MMED), Integer (ITGR), and LivaNova (LIVN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Inspire Medical Systems compare to Teleflex?

Teleflex (NYSE:TFX) and Inspire Medical Systems (NYSE:INSP) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership.

Teleflex currently has a consensus target price of $154.40, suggesting a potential upside of 13.11%. Inspire Medical Systems has a consensus target price of $68.82, suggesting a potential downside of 3.19%. Given Teleflex's stronger consensus rating and higher possible upside, research analysts clearly believe Teleflex is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex
1 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
2.67
Inspire Medical Systems
4 Sell rating(s)
12 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.05

Inspire Medical Systems has a net margin of 15.03% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Teleflex-39.67% 11.93% 5.44%
Inspire Medical Systems 15.03%8.64%7.45%

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 0.7% of Teleflex shares are owned by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Teleflex had 10 more articles in the media than Inspire Medical Systems. MarketBeat recorded 10 mentions for Teleflex and 0 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.45 beat Teleflex's score of 0.64 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Overall Sentiment
Teleflex Positive
Inspire Medical Systems Positive

Inspire Medical Systems has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teleflex$2.25B2.57-$905.64M-$23.29N/A
Inspire Medical Systems$911.98M2.25$145.42M$4.6215.39

Teleflex has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market.

Summary

Teleflex beats Inspire Medical Systems on 10 of the 17 factors compared between the two stocks.

How does Inspire Medical Systems compare to Haemonetics?

Inspire Medical Systems (NYSE:INSP) and Haemonetics (NYSE:HAE) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, valuation and profitability.

Inspire Medical Systems has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market.

Inspire Medical Systems has a net margin of 15.03% compared to Haemonetics' net margin of 7.12%. Haemonetics' return on equity of 27.55% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems15.03% 8.64% 7.45%
Haemonetics 7.12%27.55%9.65%

In the previous week, Haemonetics had 7 more articles in the media than Inspire Medical Systems. MarketBeat recorded 7 mentions for Haemonetics and 0 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.45 beat Haemonetics' score of 0.88 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Overall Sentiment
Inspire Medical Systems Positive
Haemonetics Positive

Inspire Medical Systems has higher earnings, but lower revenue than Haemonetics. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M2.25$145.42M$4.6215.39
Haemonetics$1.35B4.00$97.31M$2.0458.20

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by company insiders. Comparatively, 2.1% of Haemonetics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Inspire Medical Systems presently has a consensus price target of $68.82, indicating a potential downside of 3.19%. Haemonetics has a consensus price target of $110.00, indicating a potential downside of 7.35%. Given Inspire Medical Systems' higher possible upside, analysts clearly believe Inspire Medical Systems is more favorable than Haemonetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
4 Sell rating(s)
12 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.05
Haemonetics
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

Summary

Haemonetics beats Inspire Medical Systems on 9 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and Inspire Medical Systems (NYSE:INSP) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

Inspire Medical Systems has a net margin of 15.03% compared to MiniMed Group's net margin of 0.00%. Inspire Medical Systems' return on equity of 8.64% beat MiniMed Group's return on equity.

Company Net Margins Return on Equity Return on Assets
MiniMed GroupN/A N/A N/A
Inspire Medical Systems 15.03%8.64%7.45%

94.9% of Inspire Medical Systems shares are held by institutional investors. 0.0% of MiniMed Group shares are held by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Inspire Medical Systems' average media sentiment score of 1.45 beat MiniMed Group's score of 1.34 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Overall Sentiment
MiniMed Group Positive
Inspire Medical Systems Positive

Inspire Medical Systems has lower revenue, but higher earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MiniMed Group$3.22B1.60-$333M-$0.68N/A
Inspire Medical Systems$911.98M2.25$145.42M$4.6215.39

MiniMed Group presently has a consensus target price of $24.25, suggesting a potential upside of 32.22%. Inspire Medical Systems has a consensus target price of $68.82, suggesting a potential downside of 3.19%. Given MiniMed Group's stronger consensus rating and higher probable upside, research analysts clearly believe MiniMed Group is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiniMed Group
1 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.68
Inspire Medical Systems
4 Sell rating(s)
12 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.05

Summary

Inspire Medical Systems beats MiniMed Group on 11 of the 15 factors compared between the two stocks.

How does Inspire Medical Systems compare to Integer?

Inspire Medical Systems (NYSE:INSP) and Integer (NYSE:ITGR) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership.

Inspire Medical Systems presently has a consensus price target of $68.82, suggesting a potential downside of 3.19%. Integer has a consensus price target of $113.67, suggesting a potential downside of 10.19%. Given Inspire Medical Systems' higher possible upside, equities analysts plainly believe Inspire Medical Systems is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
4 Sell rating(s)
12 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.05
Integer
0 Sell rating(s)
11 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.08

Inspire Medical Systems has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market. Comparatively, Integer has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market.

Inspire Medical Systems has higher earnings, but lower revenue than Integer. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M2.25$145.42M$4.6215.39
Integer$1.85B2.32$102.81M$3.6634.58

Inspire Medical Systems has a net margin of 15.03% compared to Integer's net margin of 6.97%. Integer's return on equity of 12.79% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems15.03% 8.64% 7.45%
Integer 6.97%12.79%6.48%

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by company insiders. Comparatively, 1.1% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Integer had 8 more articles in the media than Inspire Medical Systems. MarketBeat recorded 8 mentions for Integer and 0 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.45 beat Integer's score of 0.47 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Overall Sentiment
Inspire Medical Systems Positive
Integer Neutral

Summary

Inspire Medical Systems beats Integer on 10 of the 17 factors compared between the two stocks.

How does Inspire Medical Systems compare to LivaNova?

LivaNova (NASDAQ:LIVN) and Inspire Medical Systems (NYSE:INSP) are both mid-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Inspire Medical Systems has lower revenue, but higher earnings than LivaNova. Inspire Medical Systems is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.39B3.21-$242.47M$3.3823.93
Inspire Medical Systems$911.98M2.25$145.42M$4.6215.39

LivaNova presently has a consensus target price of $87.75, indicating a potential upside of 8.47%. Inspire Medical Systems has a consensus target price of $68.82, indicating a potential downside of 3.19%. Given LivaNova's stronger consensus rating and higher possible upside, research analysts clearly believe LivaNova is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73
Inspire Medical Systems
4 Sell rating(s)
12 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.05

Inspire Medical Systems has a net margin of 15.03% compared to LivaNova's net margin of 12.82%. LivaNova's return on equity of 16.35% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova12.82% 16.35% 7.76%
Inspire Medical Systems 15.03%8.64%7.45%

97.6% of LivaNova shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 0.4% of LivaNova shares are held by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, LivaNova had 4 more articles in the media than Inspire Medical Systems. MarketBeat recorded 4 mentions for LivaNova and 0 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.45 beat LivaNova's score of 0.45 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Overall Sentiment
LivaNova Neutral
Inspire Medical Systems Positive

LivaNova has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.73, indicating that its stock price is 27% less volatile than the broader market.

Summary

LivaNova beats Inspire Medical Systems on 11 of the 16 factors compared between the two stocks.

Get Inspire Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INSP vs. The Competition

MetricInspire Medical SystemsHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$2.06B$5.93B$7.58B$23.23B
Dividend YieldN/A1.72%2.48%3.66%
P/E Ratio15.3926.12271.3328.19
Price / Sales2.2581.44665.2777.66
Price / Cash24.8332.6276.0132.59
Price / Book2.645.8510.624.71
Net Income$145.42M$147.49M$3.51B$1.07B
7 Day Performance3.45%0.28%1.17%0.41%
1 Month Performance0.86%-4.36%-7.13%-0.99%
1 Year Performance-8.21%3.67%1.60%4.89%

Inspire Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INSP
Inspire Medical Systems
2.6063 of 5 stars
$71.09
-2.2%
$68.82
-3.2%
-8.2%$2.06B$911.98M15.391,333
TFX
Teleflex
3.8706 of 5 stars
$129.61
-0.6%
$154.40
+19.1%
+3.3%$5.53B$1.99B14.9115,500
HAE
Haemonetics
2.8467 of 5 stars
$118.56
+0.2%
$110.00
-7.2%
+131.7%$5.38B$1.33B58.123,009
MMED
MiniMed Group
2.3434 of 5 stars
$17.79
+1.7%
$24.25
+36.3%
N/A$4.92B$3.10BN/A2,800
ITGR
Integer
2.0205 of 5 stars
$126.76
+0.0%
$109.86
-13.3%
+73.5%$4.31B$1.85B34.6311,000

Related Companies and Tools


This page (NYSE:INSP) was last updated on 10/25/2026 by MarketBeat.com Staff.
From Our Partners